Joint Ventures, VIEs and Other Investments	6 Months Ended
Mar. 27, 2026
Equity Method Investments and Joint Ventures [Abstract]
Joint Ventures, VIEs and Other Investments	Joint Ventures, VIEs and Other Investments For the Company's consolidated variable interest entities ("VIE") joint ventures, the carrying value of assets and liabilities was $119.7 million and $132.9 million, respectively, as of March 27, 2026 and $163.4 million and $144.7 million, respectively, as of September 26, 2025. There are no consolidated VIEs that have debt or credit facilities. For the Company's proportionate consolidated VIEs, the carrying value of assets and liabilities was $159.3 million and $147.2 million, respectively, as of March 27, 2026, and $143.9 million and $131.9 million, respectively, as of September 26, 2025. The carrying values of our investments in equity method joint ventures in the Consolidated Balance Sheets (reported in Other Noncurrent Assets: Miscellaneous) as of March 27, 2026 and September 26, 2025 were $38.4 million and $36.3 million, respectively. Additionally, net income (loss) from equity method joint ventures (reported in Revenue) was $2.6 million and $(0.2) million, respectively, during the three months ended March 27, 2026 and March 28, 2025, with $6.8 million and $3.5 million respectively, for the corresponding six month periods. As of March 27, 2026, the Company's equity method investment carrying values do not include material amounts exceeding their share of the respective joint ventures' reported net assets. Accounts receivable from unconsolidated joint ventures accounted for under the equity method was $15.6 million and $13.6 million as of March 27, 2026 and September 26, 2025, respectively.

Joint Ventures, VIEs and Other Investments

6 Months Ended

Mar. 27, 2026

Equity Method Investments and Joint Ventures [Abstract]

Joint Ventures, VIEs and Other Investments

For the Company's consolidated variable interest entities ("VIE") joint ventures, the carrying value of assets and liabilities was $119.7 million and $132.9 million, respectively, as of March 27, 2026 and $163.4 million and $144.7 million, respectively, as of September 26, 2025. There are no consolidated VIEs that have debt or credit facilities.

For the Company's proportionate consolidated VIEs, the carrying value of assets and liabilities was $159.3 million and $147.2 million, respectively, as of March 27, 2026, and $143.9 million and $131.9 million, respectively, as of September 26, 2025.

The carrying values of our investments in equity method joint ventures in the Consolidated Balance Sheets (reported in Other Noncurrent Assets: Miscellaneous) as of March 27, 2026 and September 26, 2025 were $38.4 million and $36.3 million, respectively. Additionally, net income (loss) from equity method joint ventures (reported in Revenue) was $2.6 million and $(0.2) million, respectively, during the three months ended March 27, 2026 and March 28, 2025, with $6.8 million and $3.5 million respectively, for the corresponding six month periods. As of March 27, 2026, the Company's equity method investment carrying values do not include material amounts exceeding their share of the respective joint ventures' reported net assets.

Accounts receivable from unconsolidated joint ventures accounted for under the equity method was $15.6 million and $13.6 million as of March 27, 2026 and September 26, 2025, respectively.